Single dose of dexamethasone is not associated with postoperative recurrence and mortality in breast cancer patients: a propensity-matched cohort study
Abstract Background Dexamethasone is widely used in cancer patients despite the concern that perioperative glucocorticoids may potentially cause immunosuppression. However, studies on the influence of dexamethasone on cancer recurrence after curative surgery have produced conflicting results. The go...
Main Authors: | Myoung Hwa Kim, Dong Wook Kim, Seho Park, Joo Heung Kim, Ki Young Lee, Jisung Hwang, Young Chul Yoo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-019-5451-5 |
Similar Items
-
The DEXA-SEPSIS study protocol: a phase II randomized double-blinded controlled trial of the effect of early dexamethasone in high-risk sepsis patients
by: Kihwan Choi, et al.
Published: (2022-09-01) -
Determination Of Interleukine-10 In Cancer Patients In Stages Iii And Iv Treated With Dexamethasone.
by: Heber Siachoque, et al.
Published: (2005-12-01) -
The role of ferroptosis in the side effects of dexamethasone
by: Hongjiang Zhao, et al.
Published: (2022-12-01) -
Anti-Human Rhinovirus 1B Activity of Dexamethasone viaGCR-Dependent Autophagy Activation
by: Jae-Sug Lee, et al.
Published: (2018-12-01) -
The effect of traumatic exposure on thymus weight level after dexamethasone application in rats
by: Knežević Milica, et al.
Published: (2022-01-01)